MAFG-AS1 is dysregulated in diverse diseases, including breast cancer, lung cancer, liver cancer, bladder cancer, colorectal cancer, gastric cancer, esophagus cancer, prostate cancer, pancreatic cancer, ovarian cancer, and glioma (Fig. 1). Here, MAFG is linked to prostate cancer.